Advertisement

Topics

PubMed Journals Articles About "Mother - Daughter Initiative (MDI) In Cervical Cancer Prevention" RSS

21:26 EDT 21st August 2018 | BioPortfolio

Mother - Daughter Initiative (MDI) In Cervical Cancer Prevention PubMed articles on BioPortfolio. Our PubMed references draw on over 21 million records from the medical literature. Here you can see the latest Mother - Daughter Initiative (MDI) In Cervical Cancer Prevention articles that have been published worldwide.

More Information about "Mother - Daughter Initiative (MDI) In Cervical Cancer Prevention" on BioPortfolio

We have published hundreds of Mother - Daughter Initiative (MDI) In Cervical Cancer Prevention news stories on BioPortfolio along with dozens of Mother - Daughter Initiative (MDI) In Cervical Cancer Prevention Clinical Trials and PubMed Articles about Mother - Daughter Initiative (MDI) In Cervical Cancer Prevention for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Mother - Daughter Initiative (MDI) In Cervical Cancer Prevention Companies in our database. You can also find out about relevant Mother - Daughter Initiative (MDI) In Cervical Cancer Prevention Drugs and Medications on this site too.

Showing "Mother Daughter Initiative Cervical Cancer Prevention" PubMed Articles 1–25 of 21,000+

Depigmented plaques on vulva.

A mother brought her 8-year-old daughter to our office for evaluation of vitiligo "down there". The skin eruption first appeared on her vulva a year earlier and was intermittently pruritic. The lesions were initially smaller and red, but had since lightened in color, coalesced, and had begun to spread to the perianal area. The patient's mother had received a call from her daughter's teacher who observed that her daughter was scratching the area and might be masturbating in class. WHAT IS YOUR DIAGNOSIS? HOW...


Cervical Cancer Screening in Women With Severe Mental Disorders: An Approach to the Spanish Context.

The incidence of invasive cervical cancer and its mortality have been reduced through primary and secondary prevention. Screening rates tend to be lower in vulnerable groups, such as people with severe mental disorders, who have a later detection of cancer and a higher mortality. The access of these women to cervical cancer screening is uncertain in our context.

The San Francisco Cancer Initiative: A Community Effort To Reduce The Population Burden Of Cancer.

The great potential for reducing the cancer burden and cancer disparities through prevention and early detection is unrealized at the population level. A new community-based coalition, the San Francisco Cancer Initiative (SF CAN), focuses on the city and county of San Francisco, where cancer is the leading cause of death. SF CAN is an integrated, cross-sector collaboration launched in November 2016. It brings together the San Francisco Department of Public Health; the University of California, San Francisc...


Development of a clinical protocol for detection of cervical cancer precursor lesions.

to develop and validate the content of a clinical protocol aimed at prevention of cervical cancer in primary care.

Human papillomavirus infection and vaccination.

Human papillomavirus (HPV) is an infection that can be sexually transmitted and result in health consequences. Persistent high-risk HPV infection can lead to various cancers and is the essential cause of cervical cancer. HPV vaccine can prevent the HPV infection and thus the incidence of cervical cancer. In this review we introduced the prevalence of HPV infection and vaccination, and the prevention and early detection of cervical cancer. We also introduced the present knowledge and awareness of HPV infecti...

Factors associated with cervical precancerous lesions among women screened for cervical cancer in Addis Ababa, Ethiopia: A case control study.

Cervical cancer is the second most prevalent cancer among women in the developing countries including Ethiopia. Precancerous lesions can be developed and risk to the development of cervical cancer over time. Early identification of the precancerous lesion and its risk factor is paramount in preventing cervical cancer. However, the determinants of cervical precancerous lesions are not well documented in Ethiopia. Therefore, this study is conducted to determine factors associated with cervical precancerous le...

Fluorescence microscopy of H&E stained cervical biopsies to assist the diagnosis and grading of CIN.

Prevention of cervical cancer is based upon the accurate diagnosis and grading of cervical lesions identified during screening. The pathological classification of cervical intraepithelial neoplasia (CIN) is problematic, as it relies on subjective criteria and is known to have high interobserver variability and low reproducibility. These limitations can result in either over or under treatment of patients. Biomarkers to improve CIN diagnosis have not overcome all these challenges.

Social Media as a Tool to Promote Health Awareness: Results from an Online Cervical Cancer Prevention Study.

Online social media platforms represent a promising opportunity for public health promotion. Research is limited, however, on the effectiveness of social media at improving knowledge and awareness of health topics and motivating healthy behavior change. Therefore, we investigated whether participation in an online social media platform and receipt of brief, tailored messages is effective at increasing knowledge, awareness, and prevention behaviors related to human papillomavirus (HPV) and cervical cancer. W...

Human papillomaviruses in Western Africa: prevalences and risk factors in Burkina Faso.

Cervical cancer is the most common cancer in women in low income countries. Certain oncogenic types of human papillomaviruses are causally associated with the cervical cancer. To ensure effective primary prevention through the introduction of a national vaccination program in Burkina Faso, information about the disease burden of HPV infection in the country is of great importance.

Anticipating the Impact of Human Papillomavirus Vaccination on US Cervical Cancer Prevention Strategies.

Cervical cancer prevention guidelines are benchmarked to risk of cervical precancer. In younger age cohorts, vaccination against high-risk types of human papillomavirus (HPV) has reduced HPV 16/18 prevalence and cervical intraepithelial neoplasia. Lower prevalence of precancer will impair the sensitivity of cytology and colposcopy, but negative predictive value will rise. Training and skills maintenance will become more difficult as abnormalities become less common. Primary screening with HPV assays will be...

The Ideal Strategy for Cervical Cancer Screening in Japan: Result from the Fukui Cervical Cancer Screening Study.

The aims of the Fukui Cervical Cancer Screening (FCCS) study are to determine the frequency of women with high-risk HPV (hrHPV), whether HPV16 or HPV18 (HPV16/18), in the Japanese cancer screening population for the first time and to identify the best strategy for cervical cancer screening in Japan.

Knowledge and attitudes about cervical cancer and its prevention among female secondary school students in Nigeria.

To ascertain the level of awareness and attitudes towards cervical cancer among secondary school students in Nigeria.

Targeting mitochondrial respiration as a therapeutic strategy for cervical cancer.

Targeting mitochondrial respiration has been documented as an effective therapeutic strategy in cancer. However, the impact of mitochondrial respiration inhibition on cervical cancer cells are not well elucidated. Using a panel of cervical cancer cell lines, we show that an existing drug atovaquone is active against the cervical cancer cells with high profiling of mitochondrial biogenesis. Atovaquone inhibited proliferation and induced apoptosis with varying efficacy among cervical cancer cell lines regardl...

Differential Expression of MicroRNAs in Uterine Cervical Cancer and Its Implications in Carcinogenesis; An Integrative Approach.

Cervical cancer is the second most common cancer in women in developing countries, including India. Recently, microRNAs (miRNAs) are gaining importance in cancer biology because of their involvement in various cellular processes. The present study aimed to profile miRNA expression pattern in cervical cancer, identify their target genes, and understand their role in carcinogenesis.

Automated Cervical Screening and Triage, Based on HPV Testing and Computer-Interpreted Cytology.

State-of-the-art cervical cancer prevention includes human papillomavirus (HPV) vaccination among adolescents and screening/treatment of cervical precancer (CIN3/AIS and, less strictly, CIN2) among adults. HPV testing provides sensitive detection of precancer but, to reduce overtreatment, secondary "triage" is needed to predict women at highest risk. Those with the highest-risk HPV types or abnormal cytology are commonly referred to colposcopy; however, expert cytology services are critically lacking in man...

Understanding women's uptake and adherence in Option B+ for prevention of mother-to-child HIV transmission in Papua, Indonesia: A qualitative study.

Despite a more proactive approach to reducing new HIV infections in infants through lifelong treatment (Option B+ policy) for infected pregnant women, prevention of mother-to-child transmission of HIV (PMTCT) has not been fully effective in Papua, Indonesia. Mother-to-child transmission (MTCT) is the second greatest risk factor for HIV infection in the community, and an elimination target of

A Culturally Sensitive Approach to Cervical Cancer Prevention in the Latina Population Using the Promotora Model.

Latina women of low socioeconomic status are particularly vulnerable to morbidity and mortality from cervical cancer. Lower rates of screening are associated with increased mortality rates in this population. Community health workers known as promotoras de salud can be an effective part of the health care team to help improve health care access in this population. Promotoras using a cervical cancer education curriculum known as AMIGAS can help promote access to services, provide education, and possibly save...

Cervical Cancer Screening: What's New? Updates for the Busy Clinician.

In the United States, 12,000 women are diagnosed with cervical cancer each year, even though the screening for this disease is safe and effective. There are 3 types of screening options available: cervical cytology ("Pap" test), Pap/HPV (human papillomavirus) co-test, and HPV (human papillomavirus)-only test. With simplified options such as HPV (human papillomavirus) -only screening, providers who have been reluctant to incorporate cervical cancer screening into their primary care practice may feel more com...

A re-audit of cervical screening uptake in a dermatology cohort on immunosuppressive medications.

The importance of Papanicolaou (Pap) smears in the early detection and prevention of cervical cancer is well documented. Since 2008 in Ireland, free cervical screening is offered to all females 3-yearly between the ages of 25-44 and 5-yearly between the ages of 45-60. Over 20% of eligible women do not participate in the national screening programme, CervicalCheck.In 2013, we audited the uptake of cervical screening amongst female patients on at least one systemic immunosuppressive agent for a chronic inflam...

Usefulness of the maximum standardized uptake value for the diagnosis and staging of patients with cervical cancer undergoing positron emission tomography/computed tomography.

Cervical cancer recently has become more common among younger women in Japan. Diagnosing early-stage cancer is straightforward using cervical cytodiagnosis and histological diagnosis. However, postmenopausal endophytic cervical cancer and skip lesions in cervical adenocarcinoma are difficult to detect. We compared the maximum standardized uptake value (SUVmax) of 18F-fluorodeoxy-glucose positron emission tomography/computed tomography (PET/CT) for primary staging of cervical cancer and evaluated the relatio...

Sesamin induces ER stress-mediated apoptosis and activates autophagy in cervical cancer cells.

Sesamin, a major lignan of sesame oil, has demonstrated anticancer properties. However, its anticancer effects on cervical cancer have not been studied. Here, we investigated the effects of sesamin on cervical cancer (HeLa) cell line and explored the underlying mechanisms.

Selection and identification of novel peptides specifically targeting human cervical cancer.

Cervical cancer is the second most commonly diagnosed cancer and the third leading cause of cancer deaths among females in underdeveloped countries. This study aimed to identify several novel cervical cancer-specific targeting peptides (CSPs) to provide new methods for the effective diagnosis and treatment of cervical cancer. Peptide library screening in vivo was performed on human cervical cancer xenografts with Ph.D.™-12 and C7C phage display peptide libraries. Two specific peptide sequences (GDALFSVPLE...

LncRNA XIST accelerates cervical cancer progression via upregulating Fus through competitively binding with miR-200a.

As one of the commonest gynecological malignancies in the world, cervical cancer brings great threat for public health. Long non-coding RNAs (LncRNAs) have been proved to be closely related to the progression of various cancers, including cervical cancer. As a tumor promoter, lncRNA XIST has been reported in various malignant tumors. In this study, we aim to explore the specific mechanism and biological function of XIST in cervical cancer. At first, the expression levels of XIST were examined in both tissue...

Cervical cancer screening among incarcerated women.

Women with a history of incarceration bear a disproportionate burden of cervical disease and have special characteristics that affect their intent and/or ability to adhere to cervical screening and follow-up recommendations. The goal of this study was to identify factors associated with cervical cancer screening and screening outcomes among incarcerated women.

Population risk factors for late-stage presentation of cervical cancer in sub-Saharan Africa.

Cervical cancer is the most prevalent malignancy in sub-Saharan Africa (SSA) with many women only seeking professional help when they are experiencing symptoms, implying late-stage malignancy and higher mortality rates. This ecological study assesses population-level exposures of SSA women to the numerous risk factors for HPV infection and cervical cancer, against late-stage presentation of cervical cancer.


Advertisement
Quick Search
Advertisement
Advertisement